drugset / Trial / NCT01485731
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
NaSingle-groupOpen-labelTreatment
Summary
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation therapy for locally advanced cervical cancer.
Timeline
- Start
- 2012-01
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nelfinavir | Other / unclassified | 875 mg | Oral |
| Background | Cisplatin | Other / unclassified | 40 mg/m2 | Intravenous |